Hygrovest Limited (HGV.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 260 Thousand AUD | 2988.89% |
| 2023 | -9000.00 AUD | 99.94% |
| 2022 | -16.34 Million AUD | -22918.31% |
| 2021 | -71 Thousand AUD | 99.83% |
| 2020 | -41.55 Million AUD | -225.24% |
| 2019 | 33.18 Million AUD | 6568.03% |
| 2018 | -513 Thousand AUD | -428.87% |
| 2017 | -97 Thousand AUD | -27.63% |
| 2016 | -76 Thousand AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -130.5 Thousand AUD | 94.16% |
| 2024 Q2 | -130.5 Thousand AUD | 0.0% |
| 2024 FY | - AUD | 100.0% |
| 2024 Q4 | - AUD | 0.0% |
| 2023 FY | -9000.00 AUD | 99.94% |
| 2023 Q3 | -2.23 Million AUD | -336.88% |
| 2023 Q2 | 943.5 Thousand AUD | 0.0% |
| 2023 Q1 | 943.5 Thousand AUD | 117.55% |
| 2023 Q4 | -2.23 Million AUD | 0.0% |
| 2022 FY | -16.34 Million AUD | -22918.31% |
| 2022 Q4 | -5.37 Million AUD | 0.0% |
| 2022 Q3 | -5.37 Million AUD | -92.41% |
| 2022 Q1 | -2.79 Million AUD | -143.76% |
| 2022 Q2 | -2.79 Million AUD | 0.0% |
| 2021 Q3 | -1.14 Million AUD | 19.07% |
| 2021 FY | -71 Thousand AUD | 99.83% |
| 2021 Q4 | -1.14 Million AUD | 0.0% |
| 2021 Q1 | -1.41 Million AUD | 70.59% |
| 2021 Q2 | -1.41 Million AUD | -0.35% |
| 2020 Q2 | -15.98 Million AUD | -0.03% |
| 2020 Q4 | -4.79 Million AUD | -0.1% |
| 2020 FY | -41.55 Million AUD | -225.24% |
| 2020 Q3 | -4.79 Million AUD | 70.01% |
| 2020 Q1 | -15.97 Million AUD | -178.46% |
| 2019 FY | 33.18 Million AUD | 6568.03% |
| 2019 Q4 | 20.36 Million AUD | -0.01% |
| 2019 Q3 | 20.36 Million AUD | 639.69% |
| 2019 Q2 | -3.77 Million AUD | 0.0% |
| 2019 Q1 | -3.77 Million AUD | 24.99% |
| 2018 Q3 | -5.03 Million AUD | -6888.19% |
| 2018 Q4 | -5.03 Million AUD | 0.0% |
| 2018 Q2 | -72 Thousand AUD | 0.0% |
| 2018 Q1 | -72 Thousand AUD | -400.0% |
| 2018 FY | -513 Thousand AUD | -428.87% |
| 2017 FY | -97 Thousand AUD | -27.63% |
| 2017 Q4 | 24 Thousand AUD | 0.0% |
| 2017 Q3 | 24 Thousand AUD | 105.27% |
| 2017 Q2 | -455.5 Thousand AUD | 0.0% |
| 2017 Q1 | -455.5 Thousand AUD | -1651.92% |
| 2016 Q4 | -26 Thousand AUD | 0.0% |
| 2016 FY | -76 Thousand AUD | 0.0% |
| 2016 Q2 | -45 Thousand AUD | 0.0% |
| 2016 Q3 | -26 Thousand AUD | 42.22% |
| 2016 Q1 | -45 Thousand AUD | 0.0% |
| 2015 Q1 | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Althea Group Holdings Limited | 2.13 Million AUD | 87.805% |
| Cann Group Limited | 3.19 Million AUD | 91.862% |
| ECS Botanics Holdings Ltd | 7.51 Million AUD | 96.539% |
| Ecofibre Limited | -1.08 Million AUD | 124.052% |
| Elixinol Wellness Limited | -1.8 Million AUD | 114.412% |
| IDT Australia Limited | 6.7 Million AUD | 96.121% |
| Invion Limited | 1 Million AUD | 74.084% |
| Little Green Pharma Ltd | 11.97 Million AUD | 97.829% |
| Live Verdure Ltd | 695.99 Thousand AUD | 62.643% |
| Medical Developments International Limited | -2.5 Million AUD | 110.4% |
| Vitura Health Limited | 34.21 Million AUD | 99.24% |
| Vita Life Sciences Limited | 42.6 Million AUD | 99.39% |